demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
colchicine PRINCIPLE ... COLCORONA
corticosteroids
ciclesonide Clemency Ezer N ...
Immunostimulants drugs
convalescent plasma treatment C3PO CONV-ERT CoV-Early ...
Early convalescent plasma. CoV-Early ...
interferon
peginterferon Feld
neutralizing antibody
bamlanivimab monotherapy BLAZE-1 phase 2 ...
bamlanivimab/etesevimab BLAZE-1 phase 2 ... BLAZE-1 phase 3 ...
casirivimab/imdevimab (Ronapreve) Cov-2067 Weinreich ... Cov-2069 ...
sotrovimab (Xevudy; VIR-7831) COMET-ICE
inhaled corticosteroids
budesonide PRINCIPLE

1 studies excluded by filtering options 0

8158 Yildiz, 2021 210excludedrisk of bias not avaialble